Načítá se...

Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent

BACKGROUND: Despite an ever-improving understanding of the molecular biology of cancer, the treatment of most cancers has not changed dramatically in the past three decades and drugs that do not discriminate between tumor cells and normal tissues remain the mainstays of anticancer therapy. Since Hsp...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Horibe, Tomohisa, Kohno, Masayuki, Haramoto, Mari, Ohara, Koji, Kawakami, Koji
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3032679/
https://ncbi.nlm.nih.gov/pubmed/21235734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!